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Introduction
Tumor necrosis factor receptor-associated periodic syn-
drome (TRAPS) is an autosomal dominant autoinflam-
matory disease characterized by periodic fever,
accompanying with attacks of abdominal pain, arthral-
gia, myalgia, erythematous rashes, periorbital edema and
conjunctivitis. Mutations in the extracellular domain of
the 55-kD tumor necrosis factor receptor (TNFRSF1A)
has been shown to be responsible for the TRAPS
syndrome.
Case Report
A sixty two years old Turkish female presented with
fever, periorbital edema, erythematous skin rash on the
face, neck and arms at age 53 on her first admission.
She had history of arthritic attacks on wrists, fingers,
knees, elbows lasting 10-15 days, once or twice a year,
which began at the age of twelve. Since the age of 50
she has experienced febrile attacks accompanying with
abdominal pain, lasting 3-4 days in every 3-4 months.
After the age of 53 she had attacks of pruritic erythema-
tous rash on the neck, arms, legs and face, and bilateral
periorbital edema as well lasting 10-14 days, once or
twice a year. She had no family history of periodic fever.
At age 55, she was diagnosed as primary Sjögren’s syn-
drome, with the findings of parotitis, dry eyes, positive
Schirmer’s test and serum ANA and Anti-SSA positivity.
Methyl prednisolon (MP) 8 mg/day and hydroxy chloro-
quine 400 mg/day was started. One year later, at age 56,
her erythematous, pruritic skin lesions repeated with
periorbital edema. MP was given 32 mg/day. ESR and
CRP levels were elevated during attacks (eg. ESR:52
mm/h, CRP:17.4 g/L). Her skin lesions disappeared after
commencement of MP. In attack free period, ESR and
CRP returned to normal levels (eg. ESR:11 mm/h,
CRP<5 g/L). MEFV mutation analysis of Exons 2 and 10
were negative by sequencing. For her periodic fever
symptoms such as 39ºC fever accompanying with
abdominal pain and skin lesions, TNFRS1 mutations
were analyzed. Exon 2,3,4,5,6,7 and intron 2-3, 4-5 and
6-7 mutations were analyzed by polymerase chain reac-
tion/sequence based typing technique. A novel mutation
on exon 7 (S168C C>G, p.Ser197Cys) was identified.
Discussion
This patient represents a novel mutation of TNFRSF1A
in a Turkish patient with signs and symptoms
of TRAPS syndrome, accompanying with primary
Sjögren’s syndrome. As reported in Japanese cases pre-
viously, this patient with a novel mutation, has milder
disease and her attacks of fever and rash respond well
to glucocorticoid therapy. Coexistence of Sjögren’s syn-
drome may have masked the clinical manifestations of
TRAPS in this patient. Without any family history, in
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